Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phospholipase pathway in Alzheimer's disease brains: decrease in Galphai in dorsolateral prefrontal cortex.

R A Young1, K Talbot, Z Y Gao

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 230 John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104-6082, USA.

Brain Research. Molecular Brain Research
|March 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpolymer complexes and polymer compatibility.

Macromolecular rapid communications·2012
Same author

Distinct cerebral perfusion patterns in FTLD and AD.

Neurology·2010
Same author

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Neurology·2010
Same author

Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia.

Neurology·2010
Same author

Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Neurology·2010
Same author

Comparing predictors of conversion and decline in mild cognitive impairment.

Neurology·2010
Same journal

Adenoviral interneuronal transportation after retrograde gene transfer in mice.

Brain research. Molecular brain research·2005
Same journal

IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2?

Brain research. Molecular brain research·2005
Same journal

Scutellariae radix extracts suppress ethanol-induced caspase-11 expression and cell death in N(2)a cells.

Brain research. Molecular brain research·2005
Same journal

Two estrogen replacement therapies differentially regulate expression of estrogen receptors alpha and beta in the hippocampus and cortex of ovariectomized rat.

Brain research. Molecular brain research·2005
Same journal

Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats.

Brain research. Molecular brain research·2005
Same journal

Partial cloning of neuronal nitric oxide synthase (nNOS) cDNA and regional distribution of nNOS mRNA in the central nervous system of the Nile tilapia Oreochromis niloticus.

Brain research. Molecular brain research·2005
See all related articles

Alzheimer's disease (AD) is linked to altered brain signaling. Researchers found significantly reduced Galphai protein levels in AD brains, indicating impairment in this crucial neuronal pathway.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cellular Signaling

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder.
  • G-protein signaling pathways are implicated in AD pathogenesis.
  • Alterations in specific G-protein subunits and their downstream effectors are suspected in AD.

Purpose of the Study:

  • To investigate alterations in G-protein-associated signaling pathways in the brain of Alzheimer's disease patients.
  • To quantify levels of specific G-protein subunits (Galpha i, o, q, betagamma) and related enzymes in AD brains.

Main Methods:

  • Quantitative immunoblotting was employed to measure protein levels.
  • Analysis included brain tissue from Alzheimer's disease cases and control subjects.
  • Levels of G-protein subunits and Phospholipase C isoforms were assessed.

Related Experiment Videos

Main Results:

  • A significant decrease in Galphai levels was observed in all examined AD cases (43.5+/-7.4% of control).
  • Galphao levels showed a slight decrease, while Galphaq and betagamma levels remained normal.
  • Phospholipase C-beta1 levels were decreased, but Phospholipase C-gamma1 levels were unchanged.
  • Total phospholipase C activity and ceramide levels were not significantly altered.

Conclusions:

  • The study demonstrates a significant impairment in the Galphai-associated signaling pathway within neurons in Alzheimer's disease.
  • Reduced Galphai levels represent a key molecular alteration in AD neuropathology.
  • These findings highlight a specific molecular defect contributing to neuronal dysfunction in Alzheimer's disease.